
Medical Affairs Outsourcing Market Report 2026
Global Outlook – By Services (Medical Writing And Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information, Other Services), By Software (Cloud Based Software, On Premise Software), By Industry (Pharmaceutical, Biopharmaceutical, Medical Devices) - Market Size, Trends, And Global Forecast 2026-2035
Medical Affairs Outsourcing Market Overview
• Medical Affairs Outsourcing market size has reached to $2.07 billion in 2025 • Expected to grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Disease Prevalence Drives Growth In Medical Affairs Outsourcing Market • Market Trend: AI and Technology-Enabled Platforms Revolutionize Medical Affairs Outsourcing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Medical Affairs Outsourcing Market?
Medical affairs outsourcing refers to the practice of hiring external firms or individuals to handle specific functions related to medical affairs within a company. Outsourcing these functions can help companies access specialized expertise, manage costs, and focus on their core business areas. Companies might outsource to contract research organizations (CROs), medical communication agencies, or other specialized service providers. The main types of medical affairs outsourcing are medical writing and publishing, medical monitoring, medical science liaisons (MSLs), medical information, and others. Medical writing and publishing refers to the creation and dissemination of scientific documents, such as clinical trial reports, regulatory submissions, and research articles, to communicate medical and scientific information clearly and accurately. The software used in these processes includes cloud-based software and on-premise software. These services are utilized by various industries, such as pharmaceuticals, biopharmaceuticals, and medical devices.
What Is The Medical Affairs Outsourcing Market Size and Share 2026?
The medical affairs outsourcing market size has grown rapidly in recent years. It will grow from $2.07 billion in 2025 to $2.3 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing complexity of regulatory requirements, rising clinical trial volumes, need for specialized medical expertise, cost optimization strategies by pharma companies, expansion of global drug development activities.What Is The Medical Affairs Outsourcing Market Growth Forecast?
The medical affairs outsourcing market size is expected to see rapid growth in the next few years. It will grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing adoption of digital medical affairs solutions, rising demand for real-world evidence generation, growth in biopharmaceutical pipelines, expansion of outsourced msl activities, increasing focus on data-driven medical strategies. Major trends in the forecast period include increasing outsourcing of medical writing functions, rising demand for remote medical monitoring services, growing use of cloud-based medical affairs platforms, expansion of msl outsourcing models, enhanced focus on compliance and regulatory support.Global Medical Affairs Outsourcing Market Segmentation
1) By Services: Medical Writing And Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information, Other Services 2) By Software: Cloud Based Software, On Premise Software 3) By Industry: Pharmaceutical, Biopharmaceutical, Medical Devices Subsegments: 1) By Medical Writing And Publishing: Regulatory Writing, Clinical Writing, Scientific Publications, Safety Writing 2) By Medical Monitoring: On-site Monitoring, Remote Monitoring, Risk-Based Monitoring 3) By Medical Science Liaisons (MSLs): MSL Training and Development, Field Medical Support, KOL Engagement and Management 4) By Medical Information: Inquiry Management, Adverse Event Reporting, Medical Content Development 5) By Other Services: Regulatory Affairs Support, Compliance Management, Pharmacovigilance, Biostatistics And Data ManagementWhat Is The Driver Of The Medical Affairs Outsourcing Market?
The increasing prevalence of infectious diseases is expected to propel the growth of the medical affairs outsourcing market going forward. Infectious diseases are infections that can be transmitted from one person to another through various means, such as direct contact, airborne particles, or vectors. The rise in infectious diseases is driven by increased urbanization, lifestyle changes, inadequate healthcare access, and environmental influences. Medical affairs outsourcing helps mitigate the increase in communication diseases by providing expertise in managing clinical trials, enhancing regulatory compliance, and improving medical communication and information, which supports better disease management and intervention strategies. For instance, in February 2024, according to the UK Health Security Agency, a UK-based governmental department, tuberculosis (TB) cases in England rose by 10.7% from 4,380 in 2022 to 4,850 in 2023. Therefore, the increasing prevalence of infectious diseases drives the medical affairs outsourcing industry.Key Players In The Global Medical Affairs Outsourcing Market
Major companies operating in the medical affairs outsourcing market are IQVIA Holdings Inc., ICON plc, Syneos Health Inc., PAREXEL International Corporation, Charles River Laboratories International Inc., Medpace Holdings Inc., Indegene Inc., Caidya Inc., Cytel Inc., Alira Health Inc., The Medical Affairs Company LLC, Bioscript Group Limited, ProPharma Group, EVERSANA, PharmaLex Group, ClinChoice, Astrix, Kantar Health, Precision Medicine Group, Envision Pharma GroupGlobal Medical Affairs Outsourcing Market Trends and Insights
Major companies operating in the medical affairs outsourcing market are focusing on technological advancements such as artificial intelligence (AI) and technology-enabled approaches to enhance data management, streamline clinical trials, and improve regulatory compliance, ultimately driving efficiency and effectiveness in disease management and intervention strategies. Artificial intelligence (AI) and technology-enabled approaches use advanced technologies to enhance efficiency, accuracy, and decision-making in managing medical data, processes, and interactions. For instance, in July 2024, Envision Pharma Group, a UK-based pharmaceutical company, launched 4Sight Drive, an AI-driven platform utilizing machine learning algorithms to detect trends, forecast outcomes, and aid decision-making within medical affairs. Its unique features encompass processing structured and unstructured data from diverse sources, providing personalized insights for each client, and evolving through user feedback. By leveraging artificial intelligence, organizations can refine their medical affairs strategies, boost stakeholder engagement, and improve patient outcomes.What Are Latest Mergers And Acquisitions In The Medical Affairs Outsourcing Market?
In June 2023, Arterex Medical Inc., a US-based medical device contract manufacturing company, acquired NextPhase Medical Devices LLC for an undisclosed amount. With this acquisition, Arterex Medical, Inc. aims to enhance its multi-capability platform, expand its manufacturing and assembly capabilities, and strengthen its customer base across North America and Europe. NextPhase Medical Devices LLC is a US-based medical device contract manufacturing company that specializes in medical affairs outsourcing.Regional Outlook
North America was the largest region in the medical affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Medical Affairs Outsourcing Market?
The medical affairs outsourcing market includes revenues earned by entities by providing services such as regulatory affairs, medical information services, clinical trial support, pharmacovigilance, medical writing, key opinion leader (KOL) management, market access support, and training and education. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Medical Affairs Outsourcing Market Report 2026?
The medical affairs outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical affairs outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Medical Affairs Outsourcing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.3 billion |
| Revenue Forecast In 2035 | $3.49 billion |
| Growth Rate | CAGR of 11.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Services, Software, Industry |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | IQVIA Holdings Inc., ICON plc, Syneos Health Inc., PAREXEL International Corporation, Charles River Laboratories International Inc., Medpace Holdings Inc., Indegene Inc., Caidya Inc., Cytel Inc., Alira Health Inc., The Medical Affairs Company LLC, Bioscript Group Limited, ProPharma Group, EVERSANA, PharmaLex Group, ClinChoice, Astrix, Kantar Health, Precision Medicine Group, Envision Pharma Group |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
